InMed had a Pre-IND meeting with FDA on INM-901
InMed said it held a Pre-IND meeting with the FDA for its INM-901 program. The company also said it is integrating FDA feedback into its development planning.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.